United States Pharmaceuticals

Kyntra Bio, Inc. (FGEN)

Kyntra Bio, Inc. experienced recent insider activity involving CEO Thane Wettig, who executed two purchase orders in November 2025. These acquisitions follow a series of buying patterns observed throughout the year. No other significant trades occurred within the last three months, reflecting a period of relative stability regarding executive equity movements.
Ticker: FGEN Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Kyntra Bio, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.6
Wettig Thane CEO Executive Director
Transaction date
Purchase
Price
419.07
Quantity 90,964 -44.1%
Value US$2,490,824
3.6
Wettig Thane CEO Executive Director
Transaction date
Purchase
Price
338.48
Quantity 75,147 -37.7%
Value US$4,830,116
3.1
Schoeneck James A Non-Executive Director
Transaction date
Purchase
Price
349.78
Quantity 9,356 -8.1%
Value US$1,829,287
3.6
Wettig Thane CEO Executive Director
Transaction date
Purchase
Price
0.35
Quantity 145,000 +36.4%
Value US$50,663
3.1
Schoeneck James A Non-Executive Director
Transaction date
Purchase
Price
0.34
Quantity 50,000 +15.4%
Value US$17,040
3.1
Schoeneck James A Non-Executive Director
Transaction date
Purchase
Price
0.35
Quantity 250,000 +339.1%
Value US$88,000
0.5
Adib Deyaa Chief Medical Officer Officer
Transaction date
Purchase
Price
1.17
Quantity 22,123 +36.9%
Value US$25,884
3.6
Wettig Thane CEO Officer
Transaction date
Purchase
Price
1.91
Quantity 50,000 +11.9%
Value US$95,470
2.9
Jeffrey Henderson Director Non-Executive Director
Transaction date
Proposed sale
Price
1.06
Quantity 2,000
Value US$2,120
2.9
Jeffrey Henderson Director Non-Executive Director
Transaction date
Proposed sale
Price
1.91
Quantity 2,000
Value US$3,820
2.9
Henderson Jeffrey William Non-Executive Director
Transaction date
Planned sale
Price
2.69
Quantity 2,000 -5.7%
Value US$5,380
2.9
Jeffrey Henderson Director Non-Executive Director
Transaction date
Proposed sale
Price
2.73
Quantity 2,000
Value US$5,460
2.8
Conterno Enrique A Chief Executive Officer Executive Director
Transaction date
Sale
Price
2.80
Quantity 1,880 -0.5%
Value US$5,264
3.6
Wettig Thane Chief Commercial Officer Officer
Transaction date
Sale
Price
16.53
Quantity 791 -0.7%
Value US$13,075
3.6
Wettig Thane Officer Officer
Transaction date
Proposed sale
Price
16.53
Quantity 791
Value US$13,075
3.9
Chung Christine SVP, China Operations Officer
Transaction date
Planned sale
Price
17.46
Quantity 1,000 -0.4%
Value US$17,460
3.9
Chung Christine SVP, China Operations Officer
Transaction date
Planned sale
Price
16.66
Quantity 5,250 -2.2%
Value US$87,465
3.9
Chung Christine SVP, China Operations Officer
Transaction date
Planned sale
Price
17.60
Quantity 6,250 -2.5%
Value US$110,000
3.9
Christine Chung Officer Officer
Transaction date
Proposed sale
Price
17.56
Quantity 62,500
Value US$1,097,500
AOIFE BRENNAN Director Non-Executive Director
Transaction date
Proposed sale
Price
17.19
Quantity 4,733
Value US$81,363
SUZANNE BLAUG Director Non-Executive Director
Transaction date
Proposed sale
Price
17.20
Quantity 8,520
Value US$146,553
JEFFREY L EDWARDS Director Non-Executive Director
Transaction date
Proposed sale
Price
17.19
Quantity 7,889
Value US$135,607
BENJAMIN CRAVATT Director Non-Executive Director
Transaction date
Proposed sale
Price
17.17
Quantity 3,944
Value US$67,723
Brennan Aoife Non-Executive Director
Transaction date
Planned sale
Price
17.52
Quantity 2,739 -8.9%
Value US$47,987
Brennan Aoife Non-Executive Director
Transaction date
Planned sale
Price
16.74
Quantity 1,994 -6.1%
Value US$33,380
EDWARDS JEFFREY L Non-Executive Director
Transaction date
Planned sale
Price
17.51
Quantity 4,624 -12.0%
Value US$80,966
EDWARDS JEFFREY L Non-Executive Director
Transaction date
Planned sale
Price
16.74
Quantity 3,265 -7.8%
Value US$54,656
Blaug Suzanne Non-Executive Director
Transaction date
Planned sale
Price
17.51
Quantity 5,169 -14.9%
Value US$90,509
Blaug Suzanne Non-Executive Director
Transaction date
Planned sale
Price
16.73
Quantity 3,351 -8.8%
Value US$56,062
Cravatt Benjamin Non-Executive Director
Transaction date
Planned sale
Price
17.51
Quantity 2,178 -7.0%
Value US$38,137
Cravatt Benjamin Non-Executive Director
Transaction date
Planned sale
Price
16.75
Quantity 1,766 -5.4%
Value US$29,580
2.9
Henderson Jeffrey William Non-Executive Director
Transaction date
Planned sale
Price
17.69
Quantity 4,994 -12.5%
Value US$88,344
2.9
Henderson Jeffrey William Non-Executive Director
Transaction date
Planned sale
Price
16.87
Quantity 2,006 -4.8%
Value US$33,841
Ho Maykin Non-Executive Director
Transaction date
Planned sale
Price
17.68
Quantity 6,225 -16.5%
Value US$110,058
Ho Maykin Non-Executive Director
Transaction date
Planned sale
Price
16.79
Quantity 2,295 -5.7%
Value US$38,533
2.9
Jeffrey Henderson Director Non-Executive Director
Transaction date
Proposed sale
Price
17.78
Quantity 7,000
Value US$124,460
May-Kin Ho Director Non-Executive Director
Transaction date
Proposed sale
Price
17.78
Quantity 8,520
Value US$151,486
3.9
Graham Juan Officer Officer
Transaction date
Proposed sale
Price
16.95
Quantity 1,050
Value US$17,797
4.0
Eisner Mark EVP, Chief Medical Officer Officer
Transaction date
Sale
Price
17.04
Quantity 2,042 -1.2%
Value US$34,792
3.6
Wettig Thane Chief Commercial Officer Officer
Transaction date
Sale
Price
17.04
Quantity 1,286 -1.1%
Value US$21,910
3.6
Wettig Thane Chief Commercial Officer Officer
Transaction date
Planned sale
Price
17.04
Quantity 472 -0.4%
Value US$8,041
2.8
Conterno Enrique A Chief Executive Officer Executive Director
Transaction date
Sale
Price
17.04
Quantity 6,106 -1.6%
Value US$104,033
2.8
Conterno Enrique A Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
17.04
Quantity 2,791 -0.7%
Value US$47,550
3.1
Schoeneck James A Non-Executive Director
Transaction date
Planned sale
Price
18.03
Quantity 7,100 -8.8%
Value US$127,987
3.9
Graham Juan Chief Financial Officer Officer
Transaction date
Sale
Price
17.04
Quantity 735 -1.0%
Value US$12,523
3.9
Graham Juan Chief Financial Officer Officer
Transaction date
Sale
Price
16.95
Quantity 1,050 -1.4%
Value US$17,797
3.9
Chung Christine SVP, China Operations Officer
Transaction date
Sale
Price
17.04
Quantity 1,532 -0.6%
Value US$26,102
3.9
Chung Christine SVP, China Operations Officer
Transaction date
Sale
Price
17.04
Quantity 739 -0.3%
Value US$12,590
3.9
Chung Christine SVP, China Operations Officer
Transaction date
Sale
Price
17.04
Quantity 1,362 -0.5%
Value US$23,202
3.1
Schoeneck James A Director Non-Executive Director
Transaction date
Proposed sale
Price
18.03
Quantity 7,100
Value US$127,987
3.9
Graham Juan Officer Officer
Transaction date
Proposed sale
Price
17.04
Quantity 1,406
Value US$23,956
3.6
Wettig Thane Officer Officer
Transaction date
Proposed sale
Price
17.04
Quantity 1,758
Value US$29,951
4.0
Eisner Mark Officer Officer
Transaction date
Proposed sale
Price
17.04
Quantity 2,042
Value US$34,792
3.9
Chung Christine Officer Officer
Transaction date
Proposed sale
Price
17.02
Quantity 3,633
Value US$61,839
4.0
Eisner Mark EVP, Chief Medical Officer Officer
Transaction date
Sale
Price
18.83
Quantity 1,090 -0.7%
Value US$20,525
4.0
Eisner Mark Officer Officer
Transaction date
Proposed sale
Price
18.83
Quantity 1,090
Value US$20,525
2.8
Conterno Enrique A Chief Executive Officer Executive Director
Transaction date
Sale
Price
19.52
Quantity 1,869 -0.5%
Value US$36,483
4.0
Eisner Mark Chief Medical Officer Officer
Transaction date
Sale
Price
18.78
Quantity 9,182 -5.2%
Value US$172,473
3.9
Chung Christine SVP, China Operations Officer
Transaction date
Sale
Price
18.78
Quantity 6,590 -2.5%
Value US$123,785
3.6
Wettig Thane Chief Commercial Officer Officer
Transaction date
Sale
Price
18.71
Quantity 905 -0.8%
Value US$16,933
3.9
Graham Juan Chief Financial Officer Officer
Transaction date
Sale
Price
20.20
Quantity 2,344 -3.1%
Value US$47,342
3.9
Graham Juan Chief Financial Officer Officer
Transaction date
Sale
Price
20.20
Quantity 1,456 -1.9%
Value US$29,407
3.9
Graham Juan Chief Financial Officer Officer
Transaction date
Sale
Price
20.20
Quantity 1,112 -1.4%
Value US$22,459
2.8
Conterno Enrique A Chief Executive Officer Executive Director
Transaction date
Sale
Price
20.20
Quantity 19,486 -4.8%
Value US$393,565
2.8
Conterno Enrique A Chief Executive Officer Executive Director
Transaction date
Sale
Price
20.20
Quantity 12,103 -2.9%
Value US$244,448
4.0
Eisner Mark Chief Medical Officer Officer
Transaction date
Sale
Price
20.20
Quantity 6,255 -3.4%
Value US$126,334
4.0
Eisner Mark Chief Medical Officer Officer
Transaction date
Sale
Price
20.20
Quantity 3,885 -2.1%
Value US$78,467
3.6
Wettig Thane Chief Commercial Officer Officer
Transaction date
Sale
Price
20.20
Quantity 4,731 -4.1%
Value US$95,553
3.6
Wettig Thane Chief Commercial Officer Officer
Transaction date
Sale
Price
20.20
Quantity 2,938 -2.5%
Value US$59,340
3.9
Chung Christine SVP, China Operations Officer
Transaction date
Sale
Price
20.20
Quantity 2,914 -1.1%
Value US$58,855
3.9
Chung Christine SVP, China Operations Officer
Transaction date
Sale
Price
20.20
Quantity 4,692 -1.8%
Value US$94,766
3.9
Graham Juan Chief Financial Officer Officer
Transaction date
Sale
Price
21.16
Quantity 2,749 -3.8%
Value US$58,158
2.8
Conterno Enrique A Chief Executive Officer Executive Director
Transaction date
Sale
Price
21.16
Quantity 24,672 -6.5%
Value US$521,958
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-17 2025-11-17 B Purchase
3.6
Wettig Thane

CEO

Executive Director
90,964 -44.1%
419.07
US$2,490,824 		90,964 -44.1% 419.07 US$2,490,824
2025-11-17 2025-11-13 B Purchase
3.6
Wettig Thane

CEO

Executive Director
75,147 -37.7%
338.48
US$4,830,116 		75,147 -37.7% 338.48 US$4,830,116
2025-07-02 2025-06-30 B Purchase
3.1
Schoeneck James A
Non-Executive Director
9,356 -8.1%
349.78
US$1,829,287 		9,356 -8.1% 349.78 US$1,829,287
2025-03-25 2025-03-24 B Purchase
3.6
Wettig Thane

CEO

Executive Director
145,000 +36.4%
0.35
US$50,663 		145,000 +36.4% 0.35 US$50,663
2025-03-24 2025-03-21 B Purchase
3.1
Schoeneck James A
Non-Executive Director
50,000 +15.4%
0.34
US$17,040 		50,000 +15.4% 0.34 US$17,040
2025-03-24 2025-03-20 B Purchase
3.1
Schoeneck James A
Non-Executive Director
250,000 +339.1%
0.35
US$88,000 		250,000 +339.1% 0.35 US$88,000
2024-06-13 2024-06-12 B Purchase
0.5
Adib Deyaa

Chief Medical Officer

Officer
22,123 +36.9%
1.17
US$25,884 		22,123 +36.9% 1.17 US$25,884
2024-03-11 2024-03-07 B Purchase
3.6
Wettig Thane

CEO

Officer
50,000 +11.9%
1.91
US$95,470 		50,000 +11.9% 1.91 US$95,470
2023-09-06 2023-09-01 PlS Planned sale
2.9
Henderson Jeffrey William
Non-Executive Director
2,000 -6.5%
1.03
US$2,060 		2,000 -6.5% 1.03 US$2,060
2023-09-01 2023-09-01 PrS Proposed sale
2.9
Jeffrey Henderson

Director

Non-Executive Director
2,000
1.06
US$2,120 		2,000 1.06 US$2,120
2023-08-08 2023-08-04 PlS Planned sale
2.9
Henderson Jeffrey William
Non-Executive Director
2,000 -6.1%
1.91
US$3,820 		2,000 -6.1% 1.91 US$3,820
2023-08-04 2023-08-04 PrS Proposed sale
2.9
Jeffrey Henderson

Director

Non-Executive Director
2,000
1.91
US$3,820 		2,000 1.91 US$3,820
2023-07-13 2023-07-11 PlS Planned sale
2.9
Henderson Jeffrey William
Non-Executive Director
2,000 -5.7%
2.69
US$5,380 		2,000 -5.7% 2.69 US$5,380
2023-07-11 2023-07-11 PrS Proposed sale
2.9
Jeffrey Henderson

Director

Non-Executive Director
2,000
2.73
US$5,460 		2,000 2.73 US$5,460
2023-07-10 2023-07-07 S Sale
2.8
Conterno Enrique A

Chief Executive Officer

Executive Director
1,880 -0.5%
2.80
US$5,264 		1,880 -0.5% 2.80 US$5,264
2023-06-26 2023-06-23 S Sale
3.6
Wettig Thane

Chief Commercial Officer

Officer
791 -0.7%
16.53
US$13,075 		791 -0.7% 16.53 US$13,075
2023-06-23 2023-06-23 PrS Proposed sale
3.6
Wettig Thane

Officer

Officer
791
16.53
US$13,075 		791 16.53 US$13,075
2023-06-15 2023-06-14 PlS Planned sale
3.9
Chung Christine

SVP, China Operations

Officer
1,000 -0.4%
17.46
US$17,460 		1,000 -0.4% 17.46 US$17,460
2023-06-15 2023-06-14 PlS Planned sale
3.9
Chung Christine

SVP, China Operations

Officer
5,250 -2.2%
16.66
US$87,465 		5,250 -2.2% 16.66 US$87,465
2023-06-15 2023-06-13 PlS Planned sale
3.9
Chung Christine

SVP, China Operations

Officer
6,250 -2.5%
17.60
US$110,000 		6,250 -2.5% 17.60 US$110,000
2023-06-13 2023-06-13 PrS Proposed sale
3.9
Christine Chung

Officer

Officer
62,500
17.56
US$1,097,500 		62,500 17.56 US$1,097,500
2023-06-09 2023-06-09 PrS Proposed sale
AOIFE BRENNAN

Director

Non-Executive Director
4,733
17.19
US$81,363 		4,733 17.19 US$81,363
2023-06-09 2023-06-09 PrS Proposed sale
SUZANNE BLAUG

Director

Non-Executive Director
8,520
17.20
US$146,553 		8,520 17.20 US$146,553
2023-06-09 2023-06-09 PrS Proposed sale
JEFFREY L EDWARDS

Director

Non-Executive Director
7,889
17.19
US$135,607 		7,889 17.19 US$135,607
2023-06-09 2023-06-09 PrS Proposed sale
BENJAMIN CRAVATT

Director

Non-Executive Director
3,944
17.17
US$67,723 		3,944 17.17 US$67,723
2023-06-09 2023-06-09 PlS Planned sale
Brennan Aoife
Non-Executive Director
2,739 -8.9%
17.52
US$47,987 		2,739 -8.9% 17.52 US$47,987
2023-06-09 2023-06-09 PlS Planned sale
Brennan Aoife
Non-Executive Director
1,994 -6.1%
16.74
US$33,380 		1,994 -6.1% 16.74 US$33,380
2023-06-09 2023-06-09 PlS Planned sale
EDWARDS JEFFREY L
Non-Executive Director
4,624 -12.0%
17.51
US$80,966 		4,624 -12.0% 17.51 US$80,966
2023-06-09 2023-06-09 PlS Planned sale
EDWARDS JEFFREY L
Non-Executive Director
3,265 -7.8%
16.74
US$54,656 		3,265 -7.8% 16.74 US$54,656
2023-06-09 2023-06-09 PlS Planned sale
Blaug Suzanne
Non-Executive Director
5,169 -14.9%
17.51
US$90,509 		5,169 -14.9% 17.51 US$90,509
2023-06-09 2023-06-09 PlS Planned sale
Blaug Suzanne
Non-Executive Director
3,351 -8.8%
16.73
US$56,062 		3,351 -8.8% 16.73 US$56,062
2023-06-09 2023-06-09 PlS Planned sale
Cravatt Benjamin
Non-Executive Director
2,178 -7.0%
17.51
US$38,137 		2,178 -7.0% 17.51 US$38,137
2023-06-09 2023-06-09 PlS Planned sale
Cravatt Benjamin
Non-Executive Director
1,766 -5.4%
16.75
US$29,580 		1,766 -5.4% 16.75 US$29,580
2023-06-09 2023-06-08 PlS Planned sale
2.9
Henderson Jeffrey William
Non-Executive Director
4,994 -12.5%
17.69
US$88,344 		4,994 -12.5% 17.69 US$88,344
2023-06-09 2023-06-08 PlS Planned sale
2.9
Henderson Jeffrey William
Non-Executive Director
2,006 -4.8%
16.87
US$33,841 		2,006 -4.8% 16.87 US$33,841
2023-06-09 2023-06-08 PlS Planned sale
Ho Maykin
Non-Executive Director
6,225 -16.5%
17.68
US$110,058 		6,225 -16.5% 17.68 US$110,058
2023-06-09 2023-06-08 PlS Planned sale
Ho Maykin
Non-Executive Director
2,295 -5.7%
16.79
US$38,533 		2,295 -5.7% 16.79 US$38,533
2023-06-08 2023-06-08 PrS Proposed sale
2.9
Jeffrey Henderson

Director

Non-Executive Director
7,000
17.78
US$124,460 		7,000 17.78 US$124,460
2023-06-08 2023-06-08 PrS Proposed sale
May-Kin Ho

Director

Non-Executive Director
8,520
17.78
US$151,486 		8,520 17.78 US$151,486
2023-06-08 2023-06-08 PrS Proposed sale
3.9
Graham Juan

Officer

Officer
1,050
16.95
US$17,797 		1,050 16.95 US$17,797
2023-06-09 2023-06-07 S Sale
4.0
Eisner Mark

EVP, Chief Medical Officer

Officer
2,042 -1.2%
17.04
US$34,792 		2,042 -1.2% 17.04 US$34,792
2023-06-09 2023-06-07 S Sale
3.6
Wettig Thane

Chief Commercial Officer

Officer
1,286 -1.1%
17.04
US$21,910 		1,286 -1.1% 17.04 US$21,910
2023-06-09 2023-06-07 PlS Planned sale
3.6
Wettig Thane

Chief Commercial Officer

Officer
472 -0.4%
17.04
US$8,041 		472 -0.4% 17.04 US$8,041
2023-06-09 2023-06-07 S Sale
2.8
Conterno Enrique A

Chief Executive Officer

Executive Director
6,106 -1.6%
17.04
US$104,033 		6,106 -1.6% 17.04 US$104,033
2023-06-09 2023-06-07 PlS Planned sale
2.8
Conterno Enrique A

Chief Executive Officer

Executive Director
2,791 -0.7%
17.04
US$47,550 		2,791 -0.7% 17.04 US$47,550
2023-06-09 2023-06-07 PlS Planned sale
3.1
Schoeneck James A
Non-Executive Director
7,100 -8.8%
18.03
US$127,987 		7,100 -8.8% 18.03 US$127,987
2023-06-09 2023-06-07 S Sale
3.9
Graham Juan

Chief Financial Officer

Officer
735 -1.0%
17.04
US$12,523 		735 -1.0% 17.04 US$12,523
2023-06-09 2023-06-07 S Sale
3.9
Graham Juan

Chief Financial Officer

Officer
1,050 -1.4%
16.95
US$17,797 		1,050 -1.4% 16.95 US$17,797
2023-06-09 2023-06-07 S Sale
3.9
Chung Christine

SVP, China Operations

Officer
1,532 -0.6%
17.04
US$26,102 		1,532 -0.6% 17.04 US$26,102
2023-06-09 2023-06-07 S Sale
3.9
Chung Christine

SVP, China Operations

Officer
739 -0.3%
17.04
US$12,590 		739 -0.3% 17.04 US$12,590
2023-06-09 2023-06-07 S Sale
3.9
Chung Christine

SVP, China Operations

Officer
1,362 -0.5%
17.04
US$23,202 		1,362 -0.5% 17.04 US$23,202
2023-06-07 2023-06-07 PrS Proposed sale
3.1
Schoeneck James A

Director

Non-Executive Director
7,100
18.03
US$127,987 		7,100 18.03 US$127,987
2023-06-07 2023-06-07 PrS Proposed sale
3.9
Graham Juan

Officer

Officer
1,406
17.04
US$23,956 		1,406 17.04 US$23,956
2023-06-07 2023-06-07 PrS Proposed sale
3.6
Wettig Thane

Officer

Officer
1,758
17.04
US$29,951 		1,758 17.04 US$29,951
2023-06-07 2023-06-07 PrS Proposed sale
4.0
Eisner Mark

Officer

Officer
2,042
17.04
US$34,792 		2,042 17.04 US$34,792
2023-06-07 2023-06-07 PrS Proposed sale
3.9
Chung Christine

Officer

Officer
3,633
17.02
US$61,839 		3,633 17.02 US$61,839
2023-06-05 2023-06-02 S Sale
4.0
Eisner Mark

EVP, Chief Medical Officer

Officer
1,090 -0.7%
18.83
US$20,525 		1,090 -0.7% 18.83 US$20,525
2023-06-02 2023-06-02 PrS Proposed sale
4.0
Eisner Mark

Officer

Officer
1,090
18.83
US$20,525 		1,090 18.83 US$20,525
2023-04-11 2023-04-10 S Sale
2.8
Conterno Enrique A

Chief Executive Officer

Executive Director
1,869 -0.5%
19.52
US$36,483 		1,869 -0.5% 19.52 US$36,483
2023-04-06 2023-04-04 S Sale
4.0
Eisner Mark

Chief Medical Officer

Officer
9,182 -5.2%
18.78
US$172,473 		9,182 -5.2% 18.78 US$172,473
2023-04-06 2023-04-04 S Sale
3.9
Chung Christine

SVP, China Operations

Officer
6,590 -2.5%
18.78
US$123,785 		6,590 -2.5% 18.78 US$123,785
2023-03-24 2023-03-23 S Sale
3.6
Wettig Thane

Chief Commercial Officer

Officer
905 -0.8%
18.71
US$16,933 		905 -0.8% 18.71 US$16,933
2023-03-10 2023-03-10 S Sale
3.9
Graham Juan

Chief Financial Officer

Officer
2,344 -3.1%
20.20
US$47,342 		2,344 -3.1% 20.20 US$47,342
2023-03-10 2023-03-10 S Sale
3.9
Graham Juan

Chief Financial Officer

Officer
1,456 -1.9%
20.20
US$29,407 		1,456 -1.9% 20.20 US$29,407
2023-03-10 2023-03-10 S Sale
3.9
Graham Juan

Chief Financial Officer

Officer
1,112 -1.4%
20.20
US$22,459 		1,112 -1.4% 20.20 US$22,459
2023-03-10 2023-03-10 S Sale
2.8
Conterno Enrique A

Chief Executive Officer

Executive Director
19,486 -4.8%
20.20
US$393,565 		19,486 -4.8% 20.20 US$393,565
2023-03-10 2023-03-10 S Sale
2.8
Conterno Enrique A

Chief Executive Officer

Executive Director
12,103 -2.9%
20.20
US$244,448 		12,103 -2.9% 20.20 US$244,448
2023-03-10 2023-03-10 S Sale
4.0
Eisner Mark

Chief Medical Officer

Officer
6,255 -3.4%
20.20
US$126,334 		6,255 -3.4% 20.20 US$126,334
2023-03-10 2023-03-10 S Sale
4.0
Eisner Mark

Chief Medical Officer

Officer
3,885 -2.1%
20.20
US$78,467 		3,885 -2.1% 20.20 US$78,467
2023-03-10 2023-03-10 S Sale
3.6
Wettig Thane

Chief Commercial Officer

Officer
4,731 -4.1%
20.20
US$95,553 		4,731 -4.1% 20.20 US$95,553
2023-03-10 2023-03-10 S Sale
3.6
Wettig Thane

Chief Commercial Officer

Officer
2,938 -2.5%
20.20
US$59,340 		2,938 -2.5% 20.20 US$59,340
2023-03-10 2023-03-10 S Sale
3.9
Chung Christine

SVP, China Operations

Officer
2,914 -1.1%
20.20
US$58,855 		2,914 -1.1% 20.20 US$58,855
2023-03-10 2023-03-10 S Sale
3.9
Chung Christine

SVP, China Operations

Officer
4,692 -1.8%
20.20
US$94,766 		4,692 -1.8% 20.20 US$94,766
2023-03-10 2023-03-08 S Sale
3.9
Graham Juan

Chief Financial Officer

Officer
2,749 -3.8%
21.16
US$58,158 		2,749 -3.8% 21.16 US$58,158
2023-03-10 2023-03-08 S Sale
2.8
Conterno Enrique A

Chief Executive Officer

Executive Director
24,672 -6.5%
21.16
US$521,958 		24,672 -6.5% 21.16 US$521,958

See older Kyntra Bio, Inc. insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Kyntra Bio, Inc. history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Kyntra Bio, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America